Your browser doesn't support javascript.
loading
Safety of Janus Kinase Inhibitors in Older Patients: A Focus on the Thromboembolic Risk.
Rajasimhan, Suraj; Pamuk, Omer; Katz, James D.
Afiliação
  • Rajasimhan S; Pharmacy Department, National Institutes of Health Clinical Center, 10 Center Drive, Bldg. 10, Room 1C240, Bethesda, MD, 20892, USA. suraj.rajasimhan@nih.gov.
  • Pamuk O; Office of the Clinical Director, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
  • Katz JD; Office of the Clinical Director, Intramural Research Program, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, USA.
Drugs Aging ; 37(8): 551-558, 2020 08.
Article em En | MEDLINE | ID: mdl-32514874
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia / Janus Quinases / Inibidores de Janus Quinases Tipo de estudo: Etiology_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Tromboembolia / Janus Quinases / Inibidores de Janus Quinases Tipo de estudo: Etiology_studies Limite: Aged / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article